Byhealth's steady capital reinvestment at decent rates of re...
Byhealth's steady capital reinvestment at decent rates of return could be indicative of its potential as a multi-bagger stock. Although the ROCE return consistency may not seem exciting, it can yield decent share price returns over the long term.
Investors Met With Slowing Returns on Capital At Byhealth (SZSE:300146)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment